Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 138

1.

A novel bone morphogenetic protein signaling in heterotypic cell interactions in prostate cancer.

Yang S, Pham LK, Liao CP, Frenkel B, Reddi AH, Roy-Burman P.

Cancer Res. 2008 Jan 1;68(1):198-205. doi: 10.1158/0008-5472.CAN-07-5074.

2.

Diverse biological effect and Smad signaling of bone morphogenetic protein 7 in prostate tumor cells.

Yang S, Zhong C, Frenkel B, Reddi AH, Roy-Burman P.

Cancer Res. 2005 Jul 1;65(13):5769-77.

3.

Influence of BMPs on the formation of osteoblastic lesions in metastatic prostate cancer.

Feeley BT, Gamradt SC, Hsu WK, Liu N, Krenek L, Robbins P, Huard J, Lieberman JR.

J Bone Miner Res. 2005 Dec;20(12):2189-99.

4.

Contextual effect of repression of bone morphogenetic protein activity in prostate cancer.

Pham LK, Liang M, Adisetiyo HA, Liao CP, Cohen MB, Tahara SM, Frenkel B, Kasahara N, Roy-Burman P.

Endocr Relat Cancer. 2013 Nov 4;20(6):861-74. doi: 10.1530/ERC-13-0100.

5.

Bone morphogenetic protein 2 is expressed by, and acts upon, mature epithelial cells in the colon.

Hardwick JC, Van Den Brink GR, Bleuming SA, Ballester I, Van Den Brande JM, Keller JJ, Offerhaus GJ, Van Deventer SJ, Peppelenbosch MP.

Gastroenterology. 2004 Jan;126(1):111-21.

PMID:
14699493
6.

Cross-talk between paracrine-acting cytokine and chemokine pathways promotes malignancy in benign human prostatic epithelium.

Ao M, Franco OE, Park D, Raman D, Williams K, Hayward SW.

Cancer Res. 2007 May 1;67(9):4244-53.

7.

Bone morphogenetic proteins.

Chen D, Zhao M, Mundy GR.

Growth Factors. 2004 Dec;22(4):233-41. Review.

PMID:
15621726
8.

A novel regulatory role for stromal-derived factor-1 signaling in bone morphogenic protein-2 osteogenic differentiation of mesenchymal C2C12 cells.

Zhu W, Boachie-Adjei O, Rawlins BA, Frenkel B, Boskey AL, Ivashkiv LB, Blobel CP.

J Biol Chem. 2007 Jun 29;282(26):18676-85.

9.
10.

Antagonistic effects of bone morphogenetic protein-4 and -7 on renal mesangial cell proliferation induced by aldosterone through MAPK activation.

Otani H, Otsuka F, Inagaki K, Takeda M, Miyoshi T, Suzuki J, Mukai T, Ogura T, Makino H.

Am J Physiol Renal Physiol. 2007 May;292(5):F1513-25.

11.

BMP suppresses PTEN expression via RAS/ERK signaling.

Beck SE, Carethers JM.

Cancer Biol Ther. 2007 Aug;6(8):1313-7.

12.

Bone morphogenetic protein-9 induces apoptosis in prostate cancer cells, the role of prostate apoptosis response-4.

Ye L, Kynaston H, Jiang WG.

Mol Cancer Res. 2008 Oct;6(10):1594-606. doi: 10.1158/1541-7786.MCR-08-0171.

13.

Osteoblasts-derived BMP-2 enhances the motility of prostate cancer cells via activation of integrins.

Lai TH, Fong YC, Fu WM, Yang RS, Tang CH.

Prostate. 2008 Sep 1;68(12):1341-53. doi: 10.1002/pros.20799.

PMID:
18512729
14.

SDF-1α/CXCR4 signaling mediates digit tip regeneration promoted by BMP-2.

Lee J, Marrero L, Yu L, Dawson LA, Muneoka K, Han M.

Dev Biol. 2013 Oct 1;382(1):98-109. doi: 10.1016/j.ydbio.2013.07.020.

15.
16.

Regulatory role of stromal cell-derived factor-1 in bone morphogenetic protein-2-induced chondrogenic differentiation in vitro.

Guang LG, Boskey AL, Zhu W.

Int J Biochem Cell Biol. 2012 Nov;44(11):1825-33. doi: 10.1016/j.biocel.2012.06.033.

PMID:
22771956
17.

Overexpression of noggin inhibits BMP-mediated growth of osteolytic prostate cancer lesions.

Feeley BT, Krenek L, Liu N, Hsu WK, Gamradt SC, Schwarz EM, Huard J, Lieberman JR.

Bone. 2006 Feb;38(2):154-66.

PMID:
16126463
18.

BMP-induced growth suppression in colon cancer cells is mediated by p21WAF1 stabilization and modulated by RAS/ERK.

Beck SE, Jung BH, Del Rosario E, Gomez J, Carethers JM.

Cell Signal. 2007 Jul;19(7):1465-72.

19.
20.

The extracellular calcium-sensing receptor reciprocally regulates the secretion of BMP-2 and the BMP antagonist Noggin in colonic myofibroblasts.

Peiris D, Pacheco I, Spencer C, MacLeod RJ.

Am J Physiol Gastrointest Liver Physiol. 2007 Mar;292(3):G753-66.

Supplemental Content

Support Center